KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Change in Accured Expenses: 2009-2025

Historic Change in Accured Expenses for Encompass Health (EHC) over the last 17 years, with Q3 2025 value amounting to $47.5 million.

  • Encompass Health's Change in Accured Expenses rose 12196.26% to $47.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $89.4 million, marking a year-over-year increase of 1231.16%. This contributed to the annual value of $52.8 million for FY2024, which is 3469.39% up from last year.
  • As of Q3 2025, Encompass Health's Change in Accured Expenses stood at $47.5 million, which was up 12196.26% from $4.7 million recorded in Q2 2025.
  • Encompass Health's Change in Accured Expenses' 5-year high stood at $75.9 million during Q2 2022, with a 5-year trough of -$57.6 million in Q4 2022.
  • Its 5-year average for Change in Accured Expenses is $5.3 million, with a median of $5.7 million in 2021.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first plummeted by 68904.11% in 2022, then skyrocketed by 56875.0% in 2024.
  • Quarter analysis of 5 years shows Encompass Health's Change in Accured Expenses stood at -$7.3 million in 2021, then tumbled by 689.04% to -$57.6 million in 2022, then skyrocketed by 102.95% to $1.7 million in 2023, then plummeted by 152.94% to -$900000.0 in 2024, then skyrocketed by 5377.78% to $47.5 million in 2025.
  • Its last three reported values are $47.5 million in Q3 2025, $4.7 million for Q2 2025, and $18.6 million during Q1 2025.